Breaking News

PCI Completes Penn Acquisition

August 4, 2014

Expands service offerings across North America and Europe

Packaging Coordinators, Inc. (PCI) has finalized its acquisition of Penn Pharmaceutical Services Ltd., a provider of drug development and manufacturing services headquartered in Wales, UK. Penn offers clinical and commercial dosage form manufacturing and packaging, labeling, and global storage, distribution and return drug services.

With the acquisition PCI and Penn Pharma’s approximately 2,800 associates will combine across 15 facilities in North America and Europe. 
PCI is principally owned by Frazier Healthcare, with partner investors QIC Global Private Equity, Greenspring Associates and Thomas, McNerney & Partners. Teneo Capital acted as the exclusive financial adviser to PCI and Frazier Healthcare, professional services firm Alvarez & Marsal provided due diligence services, and Goodwin Procter LLP acted as legal counsel for the transaction.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.